Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
Brief Communication
[키워드] Adults
BNT162b2
boost
booster vaccination
CD4
CD8
Cellular immune response
ChAdOx1
ChAdOx1 nCoV-19
Combination
comparable
elicited
first dose
Germany
greater
healthy
Heterologous
heterologous vaccine
homologous
humoral
immunogenicity
individual
induce
magnitude
Messenger RNA
mRNA
mRNA vaccine
mRNA-1273
neutralizing antibody
overlapping
phenotype
priming
profiles
reactogenicity
recipient
regimen
regimens
reported
significantly higher
Spike-specific antibody
spike-specific IgG
spike-specific T cell
the vaccine
vaccination
Vaccine
Vaccines
viral infection
[DOI] 10.1038/s41591-021-01464-w PMC 바로가기 [Article Type] Brief Communication
[DOI] 10.1038/s41591-021-01464-w PMC 바로가기 [Article Type] Brief Communication